-
Uncategorized1 month agoIntroducing Benchling Biologics: AI infrastructure for modern drug discovery (Americas Session)
Antibody discovery is being reshaped by two forces: an explosion of novel formats and the growing role of AI across the DBTL loop. But most teams...
-
Uncategorized1 month ago
Knit Health raises $11.6M for ‘fundamentally different’ approach to healthcare AI
A startup that spun out of UC Berkeley aims to improve healthcare operations by getting AI to think like a doctor would. Knit Health launched with...
-
Uncategorized1 month ago
BMS, Hengrui build 13-asset pipeline in $15B+ onco-immune deal
Of the 13 programs that the companies will advance, four will come from Hengrui Pharma and four from Bristol Myers Squibb. The remaining five assets will...
-
Uncategorized1 month agoSTAT+: Capsida says it still doesn’t know what caused gene therapy death
Capsida Biotherapeutics said Tuesday that it still had no answers in its investigation into the death of a child in a gene therapy trial last September....
-
Uncategorized1 month ago
BridgeBio stands up to Pfizer in ATTR-CM as late-stage data hint at better survival
Indirect comparisons between BridgeBio’s Attruby and Pfizer’s tafamidis products showed a numerical survival benefit with the biotech’s drug.
-
Uncategorized1 month ago
FDA turns to old drugs to address new diseases, persistent medical needs
The FDA is looking to retool drugs with sufficient evidence to support their use in other indications, particularly those with unmet need.
-
Uncategorized1 month ago
Scientists say this algae could remove microplastics from drinking water
Researchers created a special kind of algae that can grab microscopic plastic pollution out of water almost like a magnet. The algae produce limonene, an orange-scented...
-
Uncategorized1 month ago
A year after Vertex’s big launch, pain drug research faces a pivotal moment
Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going? Read More
-
Uncategorized1 month ago
Flagship startup, Serif, says it has solved non-viral gene therapy in monkeys
BOSTON — Serif Biomedicines, a startup launched last month by Flagship Pioneering, believes it has solved two technical challenges that have long prevented gene therapy from...
-
Uncategorized1 month agoSTAT+: In the battle of sepsis algorithms, performance alone doesn’t predict victory
Five years ago, the bottom fell out of sepsis prediction software. Hundreds of hospitals had adopted an algorithm from electronic health record company Epic that promised...
